Xylem (XYL) Operating Expenses (2010 - 2026)

Xylem has reported Operating Expenses for 17 years, with the latest figure at $573.0 million in Q2 2026.

• On a quarterly basis, Operating Expenses fell 2.39% year-over-year to $573.0 million in Q2 2026; TTM through Jun 2026 was $2.3 billion, a 1.89% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 2.22% from the prior year.
• Operating Expenses was $573.0 million for Q2 2026 at Xylem, up from $559.0 million in the prior quarter.
• The five-year high for Operating Expenses was $590.0 million in Q4 2024, with the low at $356.0 million in Q1 2022.
• Average Operating Expenses over 5 years is $506.3 million, with a median of $544.0 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses surged 60.96% in 2023, then fell 12.04% in 2024.
• Over 5 years, Operating Expenses stood at $376.0 million in 2022, then surged by 44.95% to $545.0 million in 2023, then gained by 8.26% to $590.0 million in 2024, then retreated by 1.86% to $579.0 million in 2025, then slipped by 1.04% to $573.0 million in 2026.
• The last three Operating Expenses figures came in at $573.0 million (Q2 2026), $559.0 million (Q1 2026), and $579.0 million (Q4 2025), per Business Quant data.